Moloney Securities Asset Management, LLC Adaptive Biotechnologies Corp Transaction History
Moloney Securities Asset Management, LLC
- $666 Million
- Q2 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 25,000 shares of ADPT stock, worth $116,750. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,000
Previous 70,240
64.41%
Holding current value
$116,750
Previous $225,000
60.0%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
186Shares Held
152MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$140 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$65.4 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$54.5 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$54 Million0.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.4MShares$53.3 Million0.38% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $667M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...